United States Self Monitoring Blood Glucose Market Size & Growth 2025-2033

Comments · 7 Views

The United States self monitoring blood glucose market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033.

United States Self Monitoring Blood Glucose Market Overview

Base Year: 2024

Historical Years: 2019–2024

Forecast Years: 2025–2033

Market Growth Rate: 6.2% (2025–2033)

The United States self-monitoring blood glucose market is seeing robust growth due to rising diabetes cases, patient preference for home diagnostics, and innovations in monitoring devices. The United States self monitoring blood glucose market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033.

United States Self Monitoring Blood Glucose Industry Trends and Drivers:

The United States self-monitoring blood glucose market is experiencing robust growth, driven by the increasing prevalence of diabetes and the growing emphasis on patient-centered care. Self-monitoring blood glucose (SMBG) devices empower patients to take control of their diabetes management by allowing them to regularly check their blood glucose levels from the comfort of their homes. The rise in diabetes awareness and education is encouraging patients to adopt self-monitoring practices, leading to a higher demand for SMBG devices. Additionally, advancements in technology have resulted in the development of more accurate, user-friendly, and portable blood glucose meters, making it easier for patients to monitor their condition effectively.

Moreover, the United States SMBG market is characterized by a diverse range of products, including traditional blood glucose meters, continuous glucose monitoring (CGM) systems, and smartphone-integrated devices. The integration of digital health technologies is transforming diabetes management, enabling patients to track their glucose levels, receive real-time feedback, and share data with healthcare providers. This trend is particularly appealing to tech-savvy consumers who seek convenience and connectivity in their healthcare solutions. Furthermore, the increasing focus on personalized medicine and tailored treatment plans is driving the demand for SMBG devices that provide comprehensive data and insights. However, the market faces challenges such as insurance coverage issues and the need for ongoing patient education. As the United States self-monitoring blood glucose market continues to evolve, addressing these challenges while enhancing product offerings will be essential for sustaining growth.

Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-self-monitoring-blood-glucose-market/requestsample

United States Self Monitoring Blood Glucose Industry Segmentation:

The report has segmented the market into the following categories:

Component Insights:

  • Glucometer Devices
  • Test Strips
  • Lancets

Regional Insights: 

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

  • Market Performance (2019–2024)
  • Market Outlook (2025–2033)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Strategic Recommendations
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–631–791–1145

disclaimer
Comments